Fischer-Valuck BW - Search Results

1

Stereotactic body radiation therapy use for high risk prostate cancer in the United States.

Patel SA, Switchenko JM, Kishan AU, Jani AB, Royce TJ, Fischer-Valuck BW. Patel SA, et al. Prostate Cancer Prostatic Dis. 2021 Jun;24(2):578-581. doi: 10.1038/s41391-020-00300-5. Epub 2020 Nov 13. Prostate Cancer Prostatic Dis. 2021. PMID: 33188271 Free PMC article. No abstract available.

2

Comparison of stereotactic body radiation therapy for biopsy-proven versus radiographically diagnosed early-stage non-small lung cancer: a single-institution experience.

Fischer-Valuck BW, Boggs H, Katz S, Durci M, Acharya S, Rosen LR. Fischer-Valuck BW, et al. Tumori. 2015 May-Jun;101(3):287-93. doi: 10.5301/tj.5000279. Epub 2015 Apr 9. Tumori. 2015. PMID: 25908031

3

A Brief Review of Low-Dose Rate (LDR) and High-Dose Rate (HDR) Brachytherapy Boost for High-Risk Prostate.

Fischer-Valuck BW, Gay HA, Patel S, Baumann BC, Michalski JM. Fischer-Valuck BW, et al. Front Oncol. 2019 Dec 10;9:1378. doi: 10.3389/fonc.2019.01378. eCollection 2019. Front Oncol. 2019. PMID: 31921640 Free PMC article. Review.

4

Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancer.

Fischer-Valuck BW, Rao YJ, Brenneman RJ, Patel PR, Filson CP, Jani AB, Liu Y, Goyal S, Xu K, Weiss A, Kucuk O, Cimmino C, Szabo S, Rossi P, Baumann BC, Pattaras J, Hershatter B, Patel SA. Fischer-Valuck BW, et al. Brachytherapy. 2020 Sep-Oct;19(5):557-566. doi: 10.1016/j.brachy.2020.05.007. Epub 2020 Jul 3. Brachytherapy. 2020. PMID: 32624405

5

Stereotactic body radiotherapy versus conventional/moderate fractionated radiation therapy with androgen deprivation therapy for unfavorable risk prostate cancer.

Patel SA, Switchenko JM, Fischer-Valuck B, Zhang C, Rose BS, Chen RC, Jani AB, Royce TJ. Patel SA, et al. Radiat Oncol. 2020 Sep 15;15(1):217. doi: 10.1186/s13014-020-01658-5. Radiat Oncol. 2020. PMID: 32933541 Free PMC article.

6

Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent Chemoradiotherapy.

Fischer-Valuck BW, Michalski JM, Harton JG, Birtle A, Christodouleas JP, Efstathiou JA, Arora VK, Kim EH, Knoche EM, Pachynski RK, Picus J, Rao YJ, Reimers M, Roth BJ, Sargos P, Smith ZL, Zaghloul MS, Gay HA, Patel SA, Baumann BC. Fischer-Valuck BW, et al. Clin Genitourin Cancer. 2021 Feb;19(1):41-46.e1. doi: 10.1016/j.clgc.2020.06.005. Epub 2020 Jun 22. Clin Genitourin Cancer. 2021. PMID: 33187904 Free PMC article.

7

Analysis of Radiation Facility Volume and Survival in Men With Lymph Node-Positive Prostate Cancer Treated With Radiation and Androgen Deprivation Therapy.

Patel SA, Goyal S, Liu Y, Moghanaki D, Patel PR, Hanasoge S, Dhere VR, Shelton JW, Godette KD, Jani AB, Hershatter B, Fischer-Valuck BW. Patel SA, et al. JAMA Netw Open. 2020 Dec 1;3(12):e2025143. doi: 10.1001/jamanetworkopen.2020.25143. JAMA Netw Open. 2020. PMID: 33301015 Free PMC article.

8

Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer.

Royce TJ, Liu Y, Milowsky MI, Efstathiou JA, Jani AB, Fischer-Valuck B, Patel SA. Royce TJ, et al. Clin Genitourin Cancer. 2021 Aug;19(4):362-368. doi: 10.1016/j.clgc.2021.03.007. Epub 2021 Mar 16. Clin Genitourin Cancer. 2021. PMID: 33839040 Free PMC article.

9

Patient-reported outcomes after Low-dose-rate versus High-dose-rate brachytherapy boost in combination with external beam radiation for intermediate and high risk prostate cancer.

Dhere VR, Fischer-Valuck BW, Goyal S, Liu Y, Morgan TM, Ghavidel E, Moghanaki DM, Hershatter BW, Patel PR, Jani AB, Godette KD, Rossi PJ, Patel SA. Dhere VR, et al. Brachytherapy. 2021 Nov-Dec;20(6):1130-1138. doi: 10.1016/j.brachy.2021.07.005. Epub 2021 Aug 18. Brachytherapy. 2021. PMID: 34417136

10

Association of race with receipt of definitive therapy for high risk prostate cancer in older men.

Patel SA, Liu Y, Mahal BA, Jani AB, Sanda MG, Royce TJ, Fischer-Valuck BW. Patel SA, et al. J Geriatr Oncol. 2022 Mar;13(2):200-206. doi: 10.1016/j.jgo.2021.09.012. Epub 2021 Sep 23. J Geriatr Oncol. 2022. PMID: 34563484 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters